Sandra Collette
Impact in
- Pulmonary and Respiratory Medicine top 0.5%
- Brain Metastases and Treatment
- Renal cell carcinoma treatment
- Genetics top 1%
- Glioma Diagnosis and Treatment
Papers in
-
- Renal cell carcinoma treatment 9
- Brain Metastases and Treatment 9
- Lung Cancer Treatments and Mutations 6
- Surgery 25
- Bladder and Urothelial Cancer Treatments 21
- Urinary and Genital Oncology Studies 5
- Co-authors
- Sandrine Marréaud (20 shared papers)Richard Sylvester (12 shared papers)Laurence Collette (17 shared papers)Martin Köcher (8 shared papers)S. Villà (3 shared papers)Riccardo Soffietti (5 shared papers)Brigitta G. Baumert (3 shared papers)Rolf‐Peter Mueller (2 shared papers)
- Journals
- Journal of Clinical Oncology (15 papers)European Urology (8 papers)Radiotherapy and Oncology (7 papers)European Journal of Cancer (6 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)
- Partner nations
- BelgiumNetherlandsGermany
In The Last Decade
Sandra Collette
74 papers receiving 6.6k citations
Sandra Collette's Hit Papers
Peers
Comparison fields: 5 of 93
- Pulmonary and Respiratory Medicine 3.1k
- Genetics 699
- Oncology 1.6k
- Surgery 2.3k
- Cancer Research 505
Countries citing papers authored by Sandra Collette
This map shows the geographic impact of Sandra Collette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Collette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Collette more than expected).
Fields of papers citing papers by Sandra Collette
This network shows the impact of papers produced by Sandra Collette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Collette. The network helps show where Sandra Collette may publish in the future.
Co-authors
The 25 scholars most cited alongside Sandra Collette, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study Hit paper breakdown → | 2010 | 1477 |
| 2 | A Prospective, Randomised EORTC Intergroup Phase 3 Study Comparing the Oncologic Outcome of Elective Nephron-Sparing Surgery and Radical Nephrectomy for Low-Stage Renal Cell Carcinoma Hit paper breakdown → | 2010 | 729 |
| 3 | Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Based Chemotherapy: EORTC Study 30986 Hit paper breakdown → | 2011 | 547 |
| 4 | EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin Hit paper breakdown → | 2015 | 465 |
| 5 | Final Results of an EORTC-GU Cancers Group Randomized Study of Maintenance Bacillus Calmette-Guérin in Intermediate- and High-risk Ta, T1 Papillary Carcinoma of the Urinary Bladder: One-third Dose Versus Full Dose and 1 Year Versus 3 Years of Maintenance Hit paper breakdown → | 2012 | 356 |
| 6 | Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Systemic Therapy: EORTC Intergroup Study 30987 Hit paper breakdown → | 2012 | 338 |
| 7 | Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib Hit paper breakdown → | 2018 | 314 |
| 8 | Phase 3 Trials of Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for 1 to 4 Brain Metastases: Individual Patient Data Meta-Analysis Hit paper breakdown → | 2015 | 312 |
| 9 | 2013 | 262 | |
| 10 | 2008 | 166 | |
| 11 | 2012 | 141 | |
| 12 | 2013 | 135 | |
| 13 | 2018 | 127 | |
| 14 | 2018 | 120 | |
| 15 | 2017 | 94 | |
| 16 | 2020 | 89 | |
| 17 | 2016 | 88 | |
| 18 | 2015 | 84 | |
| 19 | 2018 | 71 | |
| 20 | 2008 | 67 |
About Sandra Collette
Sandra Collette is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Cancer Research and Epidemiology, having authored 75 papers that have together received 6.7k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (21 papers), Renal cell carcinoma treatment (9 papers), Brain Metastases and Treatment (9 papers), Breast Cancer Treatment Studies (7 papers), Lung Cancer Treatments and Mutations (6 papers), Glioma Diagnosis and Treatment (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Urinary and Genital Oncology Studies (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (3.1k citations), Genetics (699 citations), Oncology (1.6k citations), Surgery (2.3k citations) and Cancer Research (505 citations). Sandra Collette has collaborated with scholars based in Belgium, Netherlands and Germany. Frequent co-authors include Sandrine Marréaud, Richard Sylvester, Laurence Collette, Martin Köcher, S. Villà, Riccardo Soffietti, Brigitta G. Baumert, Rolf‐Peter Mueller, C. Carrié and Egils Valeinis. Their work appears in journals such as Journal of Clinical Oncology, European Urology, Radiotherapy and Oncology, European Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.